What is a positive Hoover sign, and how does it apply to a migraine patient with brain fog and word‑finding difficulty?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hoover Sign in Migraine: A Neurological Examination Finding for Functional Weakness

The Hoover sign is a clinical test used to distinguish functional (non-organic) weakness from organic neurological weakness, and it has no direct relevance to migraine-related cognitive symptoms like brain fog or word-finding difficulty. 1, 2

What is the Hoover Sign?

The Hoover sign is performed by placing your hand under the heel of the allegedly weak leg while asking the patient to flex the hip of their normal leg against resistance:

  • In organic weakness: No pressure is felt under the weak leg's heel
  • In functional weakness: Heightened pressure is felt under the weak leg's heel due to synergistic contraction 1

The test has moderate sensitivity (63%) but high specificity (100%) for functional weakness 1, 2. This means a positive test strongly suggests functional weakness, but a negative test doesn't rule it out.

Why This Doesn't Apply to Migraine Cognitive Symptoms

Your migraine patient with brain fog and word-finding difficulty is experiencing documented cognitive dysfunction that occurs during migraine attacks, not functional weakness:

  • Objective cognitive impairment during migraine attacks includes slowed processing speed, impaired verbal memory, word-finding difficulties, and attention deficits 3, 4
  • These symptoms represent reversible brain dysfunction related to altered subcortical activity affecting the hypothalamus, hippocampus, and thalamus, plus changes in brain network connectivity 5
  • This is not a functional neurological disorder requiring Hoover sign testing

Important Clinical Pitfall

Do not conflate migraine-related cognitive symptoms with functional neurological disorder. While recent literature suggests Hoover's sign may relate to altered sensory processing and agency beyond just functional weakness 6, applying this test to migraine cognitive symptoms would be inappropriate and potentially harmful to the therapeutic relationship. The cognitive symptoms your patient describes are:

  • Well-documented ictal (during attack) phenomena 3, 4
  • Supported by objective neuropsychological testing 4
  • Part of the recognized migraine symptom complex 5

The appropriate evaluation focuses on confirming migraine diagnosis using ICHD-3 criteria and assessing for red flags (thunderclap headache, atypical aura, focal neurological deficits, impaired memory beyond typical migraine-related changes) that would warrant neuroimaging 7. The Hoover sign would only be relevant if you suspected concurrent functional limb weakness, which is an entirely separate clinical question.

Related Questions

In a patient with migraine who reports brain fog and word‑finding difficulty, which two neuropsychological domains are most likely to be impaired?
What is the Hoover test and what diagnosis does a positive result indicate?
What is the diagnosis and treatment for a patient with a mute plantar response and a positive Hoover sign, suggesting a possible upper motor neuron lesion?
In a migraine patient experiencing brain fog and word-finding difficulty during attacks, how should executive functioning be evaluated and managed?
What is the recommended preventive and acute management for a 46‑year‑old woman with two migraines per week who has failed prior therapy?
In a migraine patient experiencing brain fog and word-finding difficulty during attacks, how should executive functioning be evaluated and managed?
What are normal cardiac output values in adults and how are low and high output states defined and managed?
Do Johns Hopkins, Mayo Clinic, Memorial Sloan Kettering, and MD Anderson meet the criteria for optimal stage IV prostate cancer care, including on‑site genomic profiling, PSMA PET imaging, and availability of 177Lu‑PSMA‑617 radioligand therapy and relevant clinical trials?
Does the Medical University of South Carolina (MUSC) in South Carolina offer on‑site genomic profiling, PSMA PET imaging, and 177Lu‑PSMA‑617 therapy for stage IV prostate cancer patients?
How should I manage a patient with migraine and functional neurological disorder who presents with weakness and a positive Hoover sign on neurologist examination?
Do granulocyte colony-stimulating factor (G‑CSF) or blood transfusion cause an increase in eosinophil or lymphocyte counts?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.